Notable from Our Podcast
The April 10, 2018, podcast's featured interview highlights a Neurology® Clinical Practice article discussing the eConsult service between primary care providers and neurologists at the Ottawa Hospital in Canada. For our What's Trending feature of the week, you will hear a discussion with the editor of Neurology Today, Dr. Joseph Safdieh, on the top research advances in 2017.
Author Tip
Want to easily keep track of new articles published in Neurology in your field of interest? Sign up for e-alerts! You can customize alerts to be emailed to you about new articles by subject, title, and authors. You can also get the table of contents of all (or some) of the Neurology journals. To sign up for alerts, visit neurology.org/cgi/alerts.
From the AAN Press Room
Visit AAN.com/pressroom for the latest press releases
Are people with Parkinson disease depressed or demoralized?
People with Parkinson disease who show signs of depression may actually have a condition called demoralization. “The distinction between depression and demoralization is important because the treatment approaches are different,” said study author Brian Koo, MD, of Yale University, New Haven, Connecticut, and a member of the American Academy of Neurology. “Demoralization may be better treated with cognitive-behavioral therapy rather than antidepressant medication, which is often prescribed for depression.”
Koo BB, Chow CA, Shah DR, et al. 2018;90:e1613–e1617. doi.org/10.1212/WNL.0000000000005425
CME
Recurrent spontaneous vertigo with interictal headshaking nystagmus
Page 1097
Use of medical care biases associations between Parkinson disease and other medical conditions
Page 1099
Most-Read Articles
As of February 23, 2018
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
G. McKhann, D. Drachman, M. Folstein, et al. 1984;34:939–944. doi.org/10.1212/WNL.34.7.939
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
J.F. Kurtzke. 1983;33:1444–1452. doi.org/10.1212/WNL.33.11.1444
Parkinsonism: onset, progression, and mortality
M.M. Hoehn and M.D. Yahr. 1967;17:427–442. doi.org/10.1212/WNL.17.5.427
Neurosurgical horizons in Parkinson's disease
C.G. Goetz, M.R. De Long, R.D. Penn, and R.A.E. Bakay. 1993;43:1–7. doi.org/10.1212/WNL.43.1_Part_1.1
Autosomal dominant cerebellar phenotypes: The genotype has settled the issue
R.N. Rosenberg. 1995;45:1–5. doi.org/10.1212/WNL.45.1.1
- © 2018 American Academy of Neurology
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
